[1]胡 冬,黎定坤,毛 翔.生长抑素与乌司他丁治疗急性胰腺炎患者的临床疗效及对胃肠功能的影响[J].医学信息,2023,36(24):102-105.[doi:10.3969/j.issn.1006-1959.2023.24.022]
　HU Dong,LI Ding-kun,MAO Xiang.Clinical Efficacy of Somatostatin and Ulinastatin in the Treatment of Patients with Acute Pancreatitis and its Effect on Gastrointestinal Function[J].Journal of Medical Information,2023,36(24):102-105.[doi:10.3969/j.issn.1006-1959.2023.24.022]
点击复制

生长抑素与乌司他丁治疗急性胰腺炎患者的临床疗效及对胃肠功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年24期
页码:
102-105
栏目:
论著
出版日期:
2023-12-15

文章信息/Info

Title:
Clinical Efficacy of Somatostatin and Ulinastatin in the Treatment of Patients with Acute Pancreatitis and its Effect on Gastrointestinal Function
文章编号:
1006-1959（2023）24-0102-04
作者:
胡 冬; 黎定坤; 毛 翔
（1.南昌市第三医院急重症医学科，江西 南昌 330008；2.南昌市第三医院急诊科，江西 南昌 330008；3.南昌明州康复医院重症医学科，江西 南昌 330008）
Author(s):
HU Dong; LI Ding-kun; MAO Xiang
(1.Department of Emergency and Critical Care Medicine,Nanchang Third Hospital,Nanchang 330008,Jiangxi,China;2.Department of Emergency,Nanchang Third Hospital,Nanchang 330008,Jiangxi,China;3.Department of Critical Care Medicine,Nanchang Mingzhou Rehabilitation Hospital,Nanchang 330008,Jiangxi,China)
关键词:
急性胰腺炎; 生长抑素; 乌司他丁; 胃肠功能; 炎性因子
Keywords:
Acute pancreatitis; Somatostatin; Ulinastatin; Gastrointestinal function; Inflammatory factors
分类号:
R657.5+1
DOI:
10.3969/j.issn.1006-1959.2023.24.022
文献标志码:
A
摘要:
目的 研究生长抑素与乌司他丁治疗急性胰腺炎（AP）的临床疗效及对患者胃肠功能的影响。方法 选取2021年10月-2022年10月南昌市第三医院急重症医学科收治的72例AP患者，按照随机数字表法分为对照组（36例）和观察组（36例）。对照组给予乌司他丁治疗，观察组给予生长抑素与乌司他丁治疗，比较两组临床疗效、生化指标[血淀粉酶（AMS）、白细胞（WBC）、C-反应蛋白（CRP）]、急性胰腺炎严重程度床边指数（BISAP）、胃肠功能评分、恢复时间（腹痛消失时间、通便时间、AMS恢复正常时间、住院时间）。结果 观察组治疗总有效率为94.44%，高于对照组的77.78%（P＜0.05）；两组治疗后AMS、WBC、CRP水平均低于治疗前，且观察组AMS、WBC、CRP水平低于对照组（P＜0.05）；两组治疗后BISAP、胃肠功能评分均低于治疗前，且观察组BISAP、胃肠功能评分低于对照组（P＜0.05）；观察组腹痛消失时间、通便时间、AMS恢复正常时间及住院时间均短于对照组（P＜0.05）。结论 生长抑素联合乌司他丁治疗AP的疗效良好，可有效改善患者病情及胃肠功能，下调体内炎性损伤标志物水平，加快其临床恢复。
Abstract:
Objective To study the clinical efficacy of somatostatin and ulinastatin in the treatment of acute pancreatitis (AP) and its effect on gastrointestinal function.Methods A total of 72 patients with AP admitted to the Department of Emergency and Critical Care Medicine of Nanchang Third Hospital from October 2021 to October 2022 were selected and divided into control group (36 patients) and observation group (36 patients) according to the random number table method. The control group was treated with ulinastatin, and the observation group was treated with somatostatin and ulinastatin. The clinical efficacy, biochemical indexes [blood amylase (AMS), white blood cell (WBC), C-reactive protein (CRP)], bedside index of severity in acute pancreatitis (BISAP), gastrointestinal function score, recovery time (abdominal pain disappearance time, defecation time, AMS recovery time, hospitalization time) were compared between the two groups.Results The total effective rate of treatment in the observation group was 94.44%, which was higher than 77.78% in the control group (P<0.05). After treatment, the levels of AMS, WBC and CRP in the two groups were lower than those before treatment, and the levels of AMS, WBC and CRP in the observation group were lower than those in the control group (P<0.05). After treatment, the BISAP and gastrointestinal function scores of the two groups were lower than those before treatment, and the BISAP and gastrointestinal function scores of the observation group were lower than those of the control group (P<0.05). The disappearance time of abdominal pain, defecation time, AMS recovery time and hospitalization time in the observation group were shorter than those in the control group (P<0.05).Conclusion Somatostatin combined with ulinastatin is effective in the treatment of AP, which can effectively improve the patient’s condition and gastrointestinal function, down-regulate the level of inflammatory injury markers in vivo, and accelerate its clinical recovery.

参考文献/References:

[1]张云云,巩想平.埃索美拉唑联合奥曲肽、生长抑素治疗重症胰腺炎疗效及对患者血乳酸水平、肠道黏膜屏障功能的影响[J].陕西医学杂志,2021,50(11):1420-1422,1426.[2]Crockett SD,Wani S,Gardner TB,et al.American Gastroenterological Association Institute Guideline onInitial Management of Acute Pancreatitis[J].Gastroenterology,2018,154(4):1096-1101.[3]尹霞,孟淼,胡臻,等.奥曲肽联合乌司他丁对重症急性胰腺炎患者血清相关因子及疗效的影响[J].中国临床医生杂志,2020,48(11):1310-1313.[4]李少基,胡志华,杨昌宝,等.乌司他丁联合泮托拉唑钠对ICU重症急性胰腺炎患者的疗效及凝血功能、血液流变学的影响[J].中国急救复苏与灾害医学杂志,2020,15(7):813-816.[5]吕宇航,任倩,李青松.生长抑素联合早期肠内营养治疗对重症胰腺炎患者炎症反应及肠道功能的影响[J].浙江医学,2022,44(10):1090-1092,1096.[6]赵琪,关炳星,马骏,等.乌司他丁联合生长抑素辅助连续血液净化对重症胰腺炎患者血清HSP70、IL-15、HMGB1水平的影响[J].现代生物医学进展,2020,20(14):2745-2749.[7]中华医学会外科学分会胰腺外科学组.中国急性胰腺炎诊治指南(2021)[J].中华消化外科杂志,2021,20(7):730-739. [8]赵立涵,甄根深,姜健,等.乌司他丁+丹参+生长抑素对重症胰腺炎患者炎症及氧化应激反应的影响[J].海南医学院学报,2018,24(15):1451-1453,1458.[9]田融冰,朱红林,杨森林,等.生长抑素持续静脉滴注治疗对重症急性胰腺炎患者胃肠道功能的影响[J].解放军医药杂志,2020,32(7):60-62,67.[10]王斌,徐冬娟.前列地尔联合生长抑素对急性胰腺炎患者近期疗效、病程及实验室指标的影响[J].中国临床药学杂志,2019,28(3):188-191.[11]丁平,王选举.生长抑素与乌司他丁联合肠内营养治疗重症急性胰腺炎患者的临床研究[J].中国临床药理学杂志,2020,36(1):10-13.[12]张泽天.早期肠内营养联合乌司他丁及生长抑素对重症胰腺炎患者炎症反应及预后的影响[J].中国老年学杂志,2019,39(18):4470-4473.[13]孙衍模,陈书德,许声江.乌司他丁、生长抑素联合奥曲肽治疗急性胰腺炎的临床研究[J].中国临床药理学杂志,2019,35(23):3021-3024.[14]王桂良,邱萍,徐林芳,等.生长抑素联合乌司他丁和/或加贝酯治疗重症急性胰腺炎的临床疗效研究[J].中国全科医学,2018,21(34):4241-4245.[15]范丽青,姜顺顺,郑英兰.乌司他丁联合生长抑素治疗重症急性胰腺炎患者的临床研究[J].实用临床医药杂志,2018,22(17):40-42.[16]周超,彭波,张昌欨.乌司他丁联合生长抑素对SAP患者疗效、炎症因子及血流动力学的影响[J].中国医院药学杂志,2018,38(17):1833-1836.[17]李康,刘博,段颖.生长抑素和乌司他丁配合丹参治疗重症急性胰腺炎的价值分析[J].河北医药,2018,40(13):2004-2007.[18]刘靓懿,黄强,宿冬远,等.生长抑素对急性胰腺炎患者外周血单核细胞CARD9、BCL-10水平的影响[J].河北医药,2021,43(7):1051-1053,1058.[19]吕飞,田书芳.生长抑素辅助治疗急性胰腺炎患者对于外周血NK细胞和TNF的影响[J].临床药物治疗杂志,2019,17(5):49-52.[20]邹旺生,陈健,桑卫东.生长抑素与乌司他丁联合用药治疗重症急性胰腺炎临床疗效[J].创伤与急危重病医学,2018,6(3):182-183.[21]谢代刚,汪蓓蓓,蔡华仔.生长抑素联合奥美拉唑治疗急性胰腺炎的疗效及对患者血清炎症因子水平的影响[J].海南医学,2018,29(8):1066-1068.[22]何清,王立为.营养支持、生长抑素联合乌司他丁治疗重症急性胰腺炎疗效分析[J].临床军医杂志,2018,46(3):248-250,254.[23]王贵良,邱萍,徐林芳,等.生长抑素联用丹参或乌司他丁治疗重症急性胰腺炎疗效观察[J].重庆医学,2016,45(6):731-733.[24]邹涛,方寅.乌司他丁、生长抑素与早期肠内营养支持三联疗法在重症急性胰腺炎中的应用效果分析[J].医学综述,2020,26(23):4754-4758,4763.[25]马宁.乌司他丁联合生长抑素治疗重症急性胰腺炎患者应用疗效分析[J].中国药物与临床,2020,20(14):2349-2351.

相似文献/References:

[1]杨 井,钱 娟,王丹雯,等.急性胰腺炎的CT诊断价值分析[J].医学信息,2018,31(02):148.[doi:10.3969/j.issn.1006-1959.2018.02.056]
　YANG Jing,QIAN Juan,WANG Dan-wen,et al.Analysis of the Value of CT in the Diagnosis of Acute Pancreatitis[J].Journal of Medical Information,2018,31(24):148.[doi:10.3969/j.issn.1006-1959.2018.02.056]
[2]罗冬冬,谢光荣.生长抑素联合中药胰炎合剂治疗重症急性胰腺炎的疗效观察[J].医学信息,2018,31(04):134.[doi:10.3969/j.issn.1006-1959.2018.04.048]
　LUO Dong-dong,XIE Guang-rong.The Curative Effect of Somatostatin Combined with Chinese Medicine Pancreatitis in the Treatment of Severe Acute Pancreatitis[J].Journal of Medical Information,2018,31(24):134.[doi:10.3969/j.issn.1006-1959.2018.04.048]
[3]应结草.急性胰腺炎治疗的研究[J].医学信息,2018,31(14):32.[doi:10.3969/j.issn.1006-1959.2018.14.011]
　YING Jie-cao.Study of the Treatment of Acute Pancreatitis[J].Journal of Medical Information,2018,31(24):32.[doi:10.3969/j.issn.1006-1959.2018.14.011]
[4]谢 鹏,曹海泉,尚 娟,等.重症急性胰腺炎患者肠内营养的时机选择[J].医学信息,2018,31(17):81.[doi:10.3969/j.issn.1006-1959.2018.17.024]
　XIE Peng,CAO Hai-quan,SHANG Juan,et al.Timing of Enteral Nutrition in Patients with Severe Acute Pancreatitis[J].Journal of Medical Information,2018,31(24):81.[doi:10.3969/j.issn.1006-1959.2018.17.024]
[5]许子明,张 颖,吴月洋,等.基于圆形分布统计分析急性胰腺炎发病及死亡时间的节气特征[J].医学信息,2018,31(19):72.[doi:10.3969/j.issn.1006-1959.2018.19.023]
　XU Zi-ming,ZHANG Ying,WU Yue-yang,et al.Statistical Analysis of the Solar Terms Characteristics of Acute Pancreatitis Based on Circular Distribution[J].Journal of Medical Information,2018,31(24):72.[doi:10.3969/j.issn.1006-1959.2018.19.023]
[6]李咏梅,阎国宝.简易评分法对急性胰腺炎病情严重程度评估的价值[J].医学信息,2018,31(21):167.[doi:10.3969/j.issn.1006-1959.2018.21.049]
　LI Yong-mei,YAN Guo-bao.The Value of Simple Scoring Method in Evaluating the Severity of Acute Pancreatitis[J].Journal of Medical Information,2018,31(24):167.[doi:10.3969/j.issn.1006-1959.2018.21.049]
[7]张宏程.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].医学信息,2019,32(03):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
　ZHANG Hong-cheng.Therapeutic Effect of Somatostatin Combined with Pantoprazole on Hepatic Cirrhosis Complicated with Upper Gastrointestinal Hemorrhage[J].Journal of Medical Information,2019,32(24):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
[8]林 洁,曾繁林,朱宏泉.改善重症急性胰腺炎预后的相关研究[J].医学信息,2018,31(24):157.[doi:10.3969/j.issn.1006-1959.2018.24.047]
　LIN Jie,ZENG Fan-lin,ZHU Hong-quan.Study on Improving the Prognosis of Severe Acute Pancreatitis[J].Journal of Medical Information,2018,31(24):157.[doi:10.3969/j.issn.1006-1959.2018.24.047]
[9]刘 云,于洪波.乌司他丁与生长抑素治疗重症急性胰腺炎临床疗效观察[J].医学信息,2019,32(01):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
　LIU Yun,YU Hong-bo.Clinical Efficacy of Ulinastatin and Somatostatin in the Treatment of Severe Acute Pancreatitis[J].Journal of Medical Information,2019,32(24):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
[10]王志勇,唐森森,付海珍,等.高甘油三酯血症型急性胰腺炎严重程度和临床预后的相关性[J].医学信息,2022,35(14):57.[doi:10.3969/j.issn.1006-1959.2022.14.012]
　WANG Zhi-yong,TANG Sen-sen,FU Hai-zhen,et al.Correlation Between Severity and Clinical Prognosis of Hypertriglyceridemic Acute Pancreatitis[J].Journal of Medical Information,2022,35(24):57.[doi:10.3969/j.issn.1006-1959.2022.14.012]

更新日期/Last Update: 1900-01-01